Aehr Test Systems
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.9% | -64.7% | +119.5% | -21.0% | +2.5% | +36.1% | -23.0% | -22.1% | -9.9% | +4.3% | +91.5% | – | |
| – | -1.6% | -57.9% | +85.0% | -25.9% | +33.3% | +38.1% | -11.7% | -26.1% | +1.2% | -5.4% | +68.9% | – | |
| – | +9.8% | -71.2% | +167.7% | -16.2% | -23.7% | +33.0% | -40.5% | -12.9% | -31.6% | +32.3% | +138.1% | – | |
| – | -19.7% | +8.5% | +0.6% | +9.8% | -3.6% | +38.0% | -14.5% | +6.1% | +4.3% | +6.6% | +15.1% | – | |
| – | +3.2% | -12.9% | +22.6% | +21.4% | +1.7% | +11.3% | -23.9% | +20.1% | -6.0% | -0.1% | +26.0% | – | |
| – | -6.4% | -5.2% | +13.6% | +17.1% | -0.1% | +20.1% | -20.4% | +17.7% | -4.9% | +2.6% | +18.6% | – | |
| – | +32.9% | -137.4% | – | -93.7% | -1,051.6% | – | – | – | – | – | – | – | |
| – | +30.3% | -124.0% | – | -73.9% | -252.9% | – | – | – | – | – | – | – | |
| – | +25.0% | -65.0% | -296,400.0% | – | -240.9% | – | – | – | – | – | – | – | |
| – | +30.3% | -124.2% | – | -97.2% | -255.8% | – | – | – | – | – | – | – | |
| – | +29.5% | -117.5% | – | -60.5% | -125.5% | – | -5,717.1% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.